On May 15, 2025, Corbus Pharmaceuticals held its annual shareholders meeting, where shareholders elected directors, approved the appointment of EisnerAmper LLP as auditors for 2025, and voted on executive compensation; Rachelle Jacques was appointed as Chair of the Board.